eISSN: 2299-551X
ISSN: 0011-4553
Journal of Stomatology
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
1/2022
vol. 75
 
Share:
Share:
more
 
 
abstract:
Original paper

Long-term effects of botulinum toxin A injection on pain and quality of life in patients with myofascial pain of masticatory muscles: a retrospective study

Tuba Develi
1
,
Tansu Uzel
2
,
Emre Cesur
3
,
Sina Uçkan
2

1.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Instabul Medipol University, Fatih/Instabul, Turkey
2.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Instabul Medipol University, Turkey
3.
Department of Orthodontics, Faculty of Dentistry, Ankara Medipol University, Ankara, Turkey
J Stoma 2022; 75, 1: 13-18
Online publish date: 2022/03/06
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Favorable effects of botulinum toxin type A (BoNT/A) on muscle hyperactivity and pain has led to its’ use in the treatment of temporomandibular joint disorders, related to muscle pain and masticatory myofascial pain.

Objectives
The aim of this retrospective study was to evaluate the short- and long-term effects of trigger point injections of BoNT/A in patients with myofascial pain syndrome.

Material and methods
The study included 17 individuals aged 19-57 years (mean, 33 years), with 2 years of follow-up records. Visual analogue scale (VAS), pressure-pain threshold (PPT), and maximum mouth opening (MMO) were applied to evaluate pain and dysfunction. Mood and sleep quality were assessed using Beck’s depression inventory (BDI) and Pittsburgh sleep quality index (PSQI). All evaluations were repeated before (T0) as well as at 4 weeks (T1), 6 months (T2), and 2 years (T3) after BoNT/A injection.

Results
VAS score was lower at all 3 post-injection time points compared to T0 (p < 0.001). Significant increases in PPT and MMO measurements were also observed at T1, T2, and T3 compared to T0. BDI scores were significantly reduced at T1 and T2 compared to T0 (p < 0.05). PSQI decreased significantly between T0 and T1 (p < 0.001), but increased at T3 (p < 0.05).

Conclusions
BoNT/A injections are an effective treatment alternative that relieve myofascial pain and mouth opening restriction, and subsequently improve quality of life in both the short- and long-term.

keywords:

myofascial pain, botulinum toxin A, trigger point, depression, sleep quality

 
Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.